Fulltext

Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

Sani NM 1 , McAuslane N 2 , Kasbon SH 1 , Ahmad R 1 , Yusof FAM 1 , Patel P 3

Affiliations 

  • 1 National Pharmaceutical Regulatory Agency, Lot 36, Jalan Universiti, 46200, Petaling Jaya, Selangor, Malaysia
  • 2 Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London, SE18EZ, UK. nmcauslane@cirsci.org
  • 3 Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London, SE18EZ, UK
Ther Innov Regul Sci, 2020 Sep;54(5):1225-1226.
PMID: 32865806 DOI: 10.1007/s43441-020-00150-2

Abstract

The authors have revised Figure 1. The revised figure is presented below.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications